³Ô¹ÏÍøÕ¾

Unmedicated mental illness linked to lower COVID-19 vaccination levels

Vaccination coverage for COVID-19 is high in both people with and without mental illness, according to a large multinational study led by researchers at Karolinska Institutet and published in Nature Communications. However, Swedish registry data revealed that individuals with unmedicated mental illness have lower vaccination levels.

The researchers analysed data from seven studies in five countries (Sweden, Norway, Iceland, Estonia, and Scotland) as part of the , totalling just over 325,000 individuals, and registry data from Sweden including over 8 million individuals.

Successful vaccination campaign

The pooled analysis from the COVIDMENT cohort showed that 85 per cent of individuals were vaccinated with the first dose of the COVID-19 vaccine (until September 30, 2021). There was no statistically significant difference in vaccination levels in people with or without a mental illness diagnosis, or with or without anxiety or depressive symptoms.

Mary Barker

Mary Barker. Foto: Ulf Sirborn

“The high vaccination coverage among most individuals with mental illness shows that the COVID-19 vaccination campaign has been successful,” says lead author , postdoctoral researcher at the , Karolinska Institutet.

However, Swedish registry data revealed that individuals diagnosed with a mental illness who did not have any dispensed prescription of medication for their mental illness were 9 per cent less likely to receive the first dose of the vaccine. Moreover, individuals with substance use disorder were 16 per cent less likely to be vaccinated.

Higher risk of severe COVID-19

“More research is needed to explore the reasons behind these associations in order to improve current and future vaccination strategies and ultimately ensure equitable protection against infectious diseases,” says Mary Barker. “As individuals with mental illness are at higher risk of severe COVID-19 outcomes, high vaccination coverage is especially important in this group.”

/Public Release. View in full .